Malaria Branch, Division of Parasitic Diseases and Malaria, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Malaria Alert Centre, College of Medicine, Blantyre, Malawi.
Am J Trop Med Hyg. 2019 Feb;100(2):460-469. doi: 10.4269/ajtmh.18-0529.
The use of mobile technologies in medicine, or mHealth, holds promise to improve health worker (HW) performance, but evidence is mixed. We conducted a cluster-randomized controlled trial to evaluate the effect of text message reminders to HWs in outpatient health facilities (HFs) on quality of care for malaria, pneumonia, and diarrhea in Malawi. After a baseline HF survey (2,360 patients) in January 2015, 105 HFs were randomized to three arms: 1) text messages to HWs on malaria case management; 2) text messages to HWs on malaria, pneumonia, and diarrhea case management (latter two for children < 5 years); and 3) control arm (no messages). Messages were sent beginning April 2015 twice daily for 6 months, followed by an endline HF survey (2,536 patients) in November 2015. An intention-to-treat analysis with difference-in-differences binomial regression modeling was performed. The proportion of patients with uncomplicated malaria managed correctly increased from 42.8% to 59.6% in the control arm, from 43.7% to 55.8% in arm 1 (effect size -4.7%-points, 95% confidence interval (CI): -18.2, 8.9, = 0.50) and from 30.2% to 50.9% in arm 2 (effect size 3.9%-points, 95% CI: -14.1, 22.0, = 0.67). Prescription of first-line antibiotics to children < 5 years with clinically defined pneumonia increased in all arms, but decreased in arm 2 (effect size -4.1%-points, 95% CI: -42.0, 33.8, = 0.83). Prescription of oral rehydration solution to children with diarrhea declined slightly in all arms. We found no significant improvements in malaria, pneumonia, or diarrhea treatment after HW reminders, illustrating the importance of rigorously testing new interventions before adoption.
移动技术在医学领域的应用,即移动医疗(mHealth),有望提高卫生工作者(HW)的绩效,但证据不一。我们进行了一项集群随机对照试验,以评估门诊医疗机构(HFs)中向 HW 发送短信提醒对马拉维疟疾、肺炎和腹泻护理质量的影响。在 2015 年 1 月进行基线 HF 调查(2360 名患者)后,105 个 HF 被随机分为三组:1)疟疾病例管理的 HW 短信;2)疟疾、肺炎和腹泻病例管理的 HW 短信(后两者适用于 5 岁以下儿童);和 3)对照组(无短信)。从 2015 年 4 月开始,每天发送两条短信,持续 6 个月,随后于 2015 年 11 月进行了 HF 终线调查(2536 名患者)。采用意向治疗分析和差异差异二项式回归模型进行分析。在对照组中,未经治疗的疟疾患者的正确治疗比例从 42.8%增加到 59.6%,从 43.7%增加到 55.8%(效应大小-4.7%,95%置信区间(CI):-18.2,8.9,=0.50),从 30.2%增加到 50.9%在手臂 2 中(效应大小 3.9%,95%CI:-14.1,22.0,=0.67)。所有组中,经临床定义的肺炎的 5 岁以下儿童的一线抗生素处方均有所增加,但在手臂 2 中减少(效应大小-4.1%,95%CI:-42.0,33.8,=0.83)。所有组中,腹泻儿童口服补液盐的处方略有下降。我们发现 HW 提醒后,疟疾、肺炎或腹泻治疗没有显著改善,这表明在采用新干预措施之前,严格测试新干预措施非常重要。